India · Delayed Price · Currency is INR Vanta Bioscience Statistics
Total Valuation
BOM:540729 has a market cap or net worth of INR 159.63 million. The enterprise value is 539.06 million.
| Market Cap | 159.63M |
| Enterprise Value | 539.06M |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:540729 has 6.31 million shares outstanding. The number of shares has increased by 14.39% in one year.
| Current Share Class | 6.31M |
| Shares Outstanding | 6.31M |
| Shares Change (YoY) | +14.39% |
| Shares Change (QoQ) | +3.23% |
| Owned by Insiders (%) | 84.66% |
| Owned by Institutions (%) | n/a |
| Float | 968,250 |
Valuation Ratios
The trailing PE ratio is 168.60.
| PE Ratio | 168.60 |
| Forward PE | n/a |
| PS Ratio | 8.79 |
| PB Ratio | 0.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 497.75 |
| EV / Sales | 29.68 |
| EV / EBITDA | 28.96 |
| EV / EBIT | 85.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.80.
| Current Ratio | 1.20 |
| Quick Ratio | 0.23 |
| Debt / Equity | 1.80 |
| Debt / EBITDA | 20.45 |
| Debt / FCF | -3.15 |
| Interest Coverage | 0.81 |
Financial Efficiency
Return on equity (ROE) is 0.87% and return on invested capital (ROIC) is 1.07%.
| Return on Equity (ROE) | 0.87% |
| Return on Assets (ROA) | 0.52% |
| Return on Invested Capital (ROIC) | 1.07% |
| Return on Capital Employed (ROCE) | 1.16% |
| Weighted Average Cost of Capital (WACC) | 4.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 36 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -946,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.24% in the last 52 weeks. The beta is 1.02, so BOM:540729's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -4.24% |
| 50-Day Moving Average | 19.96 |
| 200-Day Moving Average | 23.86 |
| Relative Strength Index (RSI) | 62.61 |
| Average Volume (20 Days) | 1,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540729 had revenue of INR 18.16 million and earned 1.08 million in profits. Earnings per share was 0.15.
| Revenue | 18.16M |
| Gross Profit | 27.09M |
| Operating Income | 6.32M |
| Pretax Income | 137,000 |
| Net Income | 1.08M |
| EBITDA | 18.62M |
| EBIT | 6.32M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 1.35 million in cash and 380.78 million in debt, with a net cash position of -379.43 million or -60.11 per share.
| Cash & Cash Equivalents | 1.35M |
| Total Debt | 380.78M |
| Net Cash | -379.43M |
| Net Cash Per Share | -60.11 |
| Equity (Book Value) | 211.76M |
| Book Value Per Share | 28.87 |
| Working Capital | 23.11M |
Cash Flow
In the last 12 months, operating cash flow was -52.19 million and capital expenditures -68.72 million, giving a free cash flow of -120.92 million.
| Operating Cash Flow | -52.19M |
| Capital Expenditures | -68.72M |
| Depreciation & Amortization | 12.30M |
| Net Borrowing | 76.07M |
| Free Cash Flow | -120.92M |
| FCF Per Share | -19.16 |
Margins
Gross margin is 149.14%, with operating and profit margins of 34.77% and 5.96%.
| Gross Margin | 149.14% |
| Operating Margin | 34.77% |
| Pretax Margin | 0.75% |
| Profit Margin | 5.96% |
| EBITDA Margin | 102.49% |
| EBIT Margin | 34.77% |
| FCF Margin | n/a |
Dividends & Yields
BOM:540729 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.39% |
| Shareholder Yield | -14.39% |
| Earnings Yield | 0.68% |
| FCF Yield | -75.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |